GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/19/2026 4:34:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2027 ending: 6/30/2026 | Rev: $10,763 | Assets $2,796,006 | EPS -$0.53 | |
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/14/2026 3:26:08 PM | Micro | View | Financials | 10-K | SEC | Y 2026 ending: 3/31/2026 | ||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 3/9/2026 7:52:31 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 12/31/2025 | ||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 12/5/2025 4:53:30 PM | View | Proxy | SEC | Y 2024 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/26/2025 5:31:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 9/30/2025 | ||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 9/10/2025 4:12:07 PM | Micro | View | Financials | 10-QT | SEC | 1Q 2026 ending: 6/30/2025 | Assets $6,488,200 | EPS -$1.37 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/13/2025 3:33:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $988,650 | EPS -$2.75 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 3/31/2025 2:15:25 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $1,955,913 | EPS -$1.13 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 3/10/2025 6:01:35 AM | View | Proxy | SEC | Y 2024 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 1/3/2025 5:04:34 PM | View | Proxy | SEC | Y 2024 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/14/2024 4:30:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $1,508,327 | EPS -$0.14 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/14/2024 5:06:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $1,467,077 | EPS -$0.36 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/15/2024 4:48:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $2,578,558 | EPS -$0.39 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/14/2024 6:15:57 AM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $4,323,369 | EPS -$1.15 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/24/2024 6:18:34 AM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $4,323,369 | EPS -$1.15 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/1/2024 4:21:21 PM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $2,578,558 | EPS -$0.39 | Export Earnings Model | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/1/2024 4:20:40 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $4,323,369 | EPS -$1.15 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/14/2023 4:39:35 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $5,432,642 | EPS -$0.32 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/2/2023 4:31:48 PM | View | Proxy | SEC | Y 2022 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/14/2023 3:45:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $6,919,121 | EPS -$0.28 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/15/2023 2:32:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $7,666,288 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/17/2023 3:03:00 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Assets $8,037,420 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 3/31/2023 3:21:50 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $8,037,420 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/14/2022 2:30:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $8,254,296 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 10/12/2022 6:02:09 AM | View | Proxy | SEC | Y 2021 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/11/2022 4:19:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $9,014,508 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/13/2022 6:46:37 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $9,798,288 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/7/2022 5:16:31 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $11,059,923 | EPS -$0.31 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/16/2021 9:59:57 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $11,657,105 | Export Earnings Model | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/15/2021 5:01:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $11,657,105 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 9/8/2021 12:13:05 PM | View | Proxy | SEC | Y 2020 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/19/2021 6:03:25 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $12,062,140 | Export Earnings Model | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/16/2021 5:12:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $12,062,140 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/17/2021 3:45:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $196,142 | |||
| Protagenic Therapeutics, Inc.\new (PTIX) | 3/25/2021 6:15:14 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $879,247 | EPS -$0.25 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/16/2020 3:52:50 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $1,002,014 | EPS -$0.10 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/28/2020 1:50:13 PM | View | Proxy | SEC | Y 2019 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/14/2020 4:55:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $1,187,911 | EPS -$0.06 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 6/18/2020 5:15:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $785,848 | EPS -$0.05 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/29/2020 6:34:56 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $842,273 | EPS -$0.17 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/14/2019 3:24:27 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $287,291 | EPS -$0.01 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/14/2019 4:53:27 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $349,768 | EPS -$0.03 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/12/2019 4:28:11 PM | View | Proxy | SEC | Y 2018 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/16/2019 3:44:58 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2019 ending: 3/31/2019 | Assets $464,781 | EPS -$0.06 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 3/29/2019 5:38:29 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $696,884 | EPS -$0.25 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/8/2018 1:54:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $990,451 | EPS -$0.05 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/14/2018 4:09:51 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $1,092,429 | EPS -$0.07 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 6/13/2018 6:07:00 AM | View | Proxy | SEC | Y 2017 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/15/2018 6:46:27 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $1,469,044 | EPS -$0.06 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/2/2018 5:49:35 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $1,781,004 | EPS -$0.22 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/13/2017 3:41:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $2,219,752 | EPS -$0.04 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/8/2017 11:34:15 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $2,454,908 | EPS -$0.04 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/26/2017 9:01:07 AM | View | Proxy | SEC | Y 2016 | ||||||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/15/2017 4:05:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $2,769,378 | EPS -$0.06 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/15/2017 4:05:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $2,769,378 | EPS -$0.06 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 5/8/2017 6:11:16 AM | Micro | View | Financials | 10-K/A | SEC | Y 2016 ending: 12/31/2016 | Assets $3,161,912 | EPS -$0.43 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 4/18/2017 6:15:41 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $3,161,912 | EPS -$0.43 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 11/17/2016 5:21:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $3,586,916 | EPS -$0.06 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 8/15/2016 3:29:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $3,789,628 | EPS -$0.08 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 7/25/2016 6:14:52 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $60,000 | EPS -$0.07 | ||
| Protagenic Therapeutics, Inc.\new (PTIX) | 7/25/2016 6:14:52 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $3,752,361 | EPS -$52.83 | ||
| Atrinsic, Inc. (PTIX) | 5/3/2016 3:12:40 PM | View | Proxy | SEC | Y 2015 | ||||||
| Atrinsic, Inc. (PTIX) | 3/11/2016 4:53:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 12/31/2015 | Assets $3,789,628 | EPS -$0.08 | ||
| Atrinsic, Inc. (PTIX) | 11/13/2015 4:05:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 9/30/2015 | Assets $60,000 | EPS -$0.07 | ||
| Atrinsic, Inc. (PTIX) | 11/13/2015 4:05:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 9/30/2015 | Assets $3,752,361 | EPS -$52.83 | ||
| Atrinsic, Inc. (PTIX) | 9/25/2015 4:52:24 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 6/30/2015 | Assets $11,142 | EPS -$0.15 | ||
| Atrinsic, Inc. (PTIX) | 9/25/2015 4:52:24 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 6/30/2015 | Assets $133,000 | |||
| Atrinsic, Inc. (PTIX) | 5/11/2015 5:29:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 3/31/2015 | Assets $148,000 | |||
| Atrinsic, Inc. (PTIX) | 2/6/2015 5:21:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 12/31/2014 | Assets $26,880 | |||
| Atrinsic, Inc. (PTIX) | 11/13/2014 4:08:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 9/30/2014 | Assets $246,000 | |||
| Atrinsic, Inc. (PTIX) | 10/14/2014 4:33:23 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 6/30/2014 | Assets $246,000 | |||
| ATRINSIC, INC. (PTIX) | 11/14/2011 2:43:04 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | ||||
| ATRINSIC, INC. (PTIX) | 9/7/2011 3:28:16 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | ||||
| Atrinsic, Inc. (PTIX) | 4/1/2011 2:15:39 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| Atrinsic, Inc. (PTIX) | 11/15/2010 5:31:00 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| Atrinsic, Inc. (PTIX) | 10/22/2010 6:58:29 PM | View | Proxy | SEC | |||||||
| Atrinsic, Inc. (PTIX) | 8/16/2010 6:12:33 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| Atrinsic, Inc. (PTIX) | 5/11/2010 10:20:01 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| Atrinsic, Inc. (PTIX) | 3/31/2010 6:07:36 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| Atrinsic, Inc. (PTIX) | 11/16/2009 3:08:33 PM | View | Conf. Call | SEC | 2Q 2016 | ||||||
| Atrinsic, Inc. (PTIX) | 11/12/2009 8:28:16 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| Atrinsic, Inc. (PTIX) | 8/14/2009 7:33:35 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| NEW MOTION, INC. (PTIX) | 5/26/2009 5:06:44 PM | View | Proxy | SEC | |||||||
| NEW MOTION, INC. (PTIX) | 5/12/2009 7:31:39 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| NEW MOTION, INC. (PTIX) | 3/26/2009 8:15:38 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model | |
| NEW MOTION, INC. (PTIX) | 2/17/2009 5:27:42 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $3,586,916 | EPS -$0.06 | Export Earnings Model |